Doucet M Y, Jones T R, Ford-Hutchinson A W
Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Qué., Canada.
Can J Physiol Pharmacol. 1990 Mar;68(3):379-83. doi: 10.1139/y90-053.
The responses of equine trachealis and lung parenchymal strips to a range of contractile agonists were studied. Equine trachealis responded to methacholine greater than histamine greater than serotonin as shown by the maximal responses but failed to respond to either leukotrienes (LT), prostaglandin F2 alpha, or U-44069. Equine parenchymal strips showed considerable tonal activity and responded to LTD4 congruent to LTC4 greater than U-44069 = LTE4 greater than methacholine congruent to histamine congruent to serotonin greater than prostaglandin F2 alpha as determined through pD2 values. Neither the concentration response curve to LTD4 nor the intrinsic tonal activity of the preparations was modified by pretreatment with either atropine or indomethacin, although the maximal response to LTD4 was reversed by addition of the LTD4 receptor antagonist, MK-571. Thus arachidonic acid metabolites, including LTs, must be considered potential mediators of equine small airway disease, a potential model of human bronchial asthma.
研究了马气管平滑肌条和肺实质条对一系列收缩性激动剂的反应。马气管平滑肌条对乙酰甲胆碱的反应大于组胺大于5-羟色胺,这由最大反应显示,但对白三烯(LT)、前列腺素F2α或U-44069均无反应。通过pD2值测定,马肺实质条显示出相当大的张力活性,对LTD4的反应等同于LTC4大于U-44069 = LTE4大于乙酰甲胆碱等同于组胺等同于5-羟色胺大于前列腺素F2α。尽管用阿托品或吲哚美辛预处理均未改变对LTD4的浓度反应曲线或制剂的内在张力活性,但加入LTD4受体拮抗剂MK-571可逆转对LTD4的最大反应。因此,包括白三烯在内的花生四烯酸代谢产物必须被视为马小气道疾病的潜在介质,这是人类支气管哮喘的一个潜在模型。